During the past decade, Clinical Research Institute Saltillo S.A. de C.V. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute Saltillo S.A. de C.V." #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "InDex Pharmaceuticals" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Mallinckrodt" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute Saltillo S.A. de C.V." are "COVID-19" (3 trials), "Lung Diseases, Interstitial" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Atopic Dermatitis" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Clinical Research Institute Saltillo S.A. de C.V." in a lesser frequency.

Most popular intervention types in "Clinical Research Institute Saltillo S.A. de C.V." are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute Saltillo S.A. de C.V." are 10 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Institute Saltillo S.A. de C.V.". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clinical Research Institute Saltillo S.A. de C.V., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute Saltillo S.A. de C.V., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".